Literature DB >> 11118446

Molecular rulers: an assessment of distance and spatial relationships of Src tyrosine kinase Sh2 and active site regions.

A A Profit1, T R Lee, J Niu, D S Lawrence.   

Abstract

The three-dimensional structures of the inactive conformations of Hck and Src, members of the Src protein-tyrosine kinase family, have recently been described. In both cases, the catalytic domain lies on the opposite face of the enzyme from the SH2 and SH3 domains. The active conformation of these enzymes has not yet been described. Given the known role of the SH2 and SH3 domains in promoting substrate binding, enzyme activation likely reorients the relative spatial arrangement between the SH2/SH3 domains and the active site region. We describe herein a series of "molecular rulers" and their use in assessing the topological and spatial relationships of the SH2 and active site regions of the Src protein-tyrosine kinase. These synthetic compounds contain sequences that are active site-directed (-Glu-Glu-Ile-Ile-(F(5))Phe-, where (F(5))Phe is pentafluorophenylalanine) and SH2-directed (-Tyr(P)-Glu-Glu-Ile-Glu-), separated by a sequence of variable length. The most potent bivalent compound, acetyl-Glu-Glu-Leu-Leu-(F(5))Phe-(GABA)(3)-Tyr(P)-Glu-Glu-Ile-Glu-amide (where GABA is gamma-aminobutyric acid), displays a >120-fold enhancement in inhibitory potency relative to the simple monovalent active site-directed species, acetyl-Glu-Glu-Leu-Leu-(F(5))Phe-amide. The short linker length (3 GABA residues) between the active site- and SH2-directed peptide fragments suggests that the corresponding domains on the Src kinase can assume a nearly contiguous spatial arrangement in the active form of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118446     DOI: 10.1074/jbc.M009262200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitors.

Authors:  Zachary B Hill; B Gayani K Perera; Simeon S Andrews; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2011-12-22       Impact factor: 5.100

2.  Quantitative relation between intermolecular and intramolecular binding of pro-rich peptides to SH3 domains.

Authors:  Huan-Xiang Zhou
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

3.  Acquisition of a "Group A"-selective Src kinase inhibitor via a global targeting strategy.

Authors:  Jung-Mi Hah; Vyas Sharma; Haishan Li; David S Lawrence
Journal:  J Am Chem Soc       Date:  2006-05-10       Impact factor: 15.419

4.  Bivalent peptides as PDZ domain ligands.

Authors:  Edvin Klosi; Dorina Saro; Mark R Spaller
Journal:  Bioorg Med Chem Lett       Date:  2007-09-12       Impact factor: 2.823

5.  Selection and optimization of enzyme reporters for chemical cytometry.

Authors:  Angela Proctor; Qunzhao Wang; David S Lawrence; Nancy L Allbritton
Journal:  Methods Enzymol       Date:  2019-03-23       Impact factor: 1.600

6.  Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity.

Authors:  Zachary B Hill; B Gayani K Perera; Dustin J Maly
Journal:  Mol Biosyst       Date:  2010-11-09

7.  Evidence of π-stacking interactions in the self-assembly of hIAPP(22-29).

Authors:  Adam A Profit; Valentina Felsen; Justina Chinwong; Elmer-Rico E Mojica; Ruel Z B Desamero
Journal:  Proteins       Date:  2013-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.